ID   OBSL1_HUMAN             Reviewed;        1896 AA.
AC   O75147; A4KVA4; A4KVA5; Q96IW3; S4R3M6;
DT   22-AUG-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 4.
DT   15-MAR-2017, entry version 144.
DE   RecName: Full=Obscurin-like protein 1;
GN   Name=OBSL1; Synonyms=KIAA0657;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=17289344; DOI=10.1016/j.ygeno.2006.12.004;
RA   Geisler S.B., Robinson D., Hauringa M., Raeker M.O., Borisov A.B.,
RA   Westfall M.V., Russell M.W.;
RT   "Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to
RT   obscurin.";
RL   Genomics 89:521-531(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 165-1896 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   INVOLVEMENT IN 3M2.
RX   PubMed=19481195; DOI=10.1016/j.ajhg.2009.04.021;
RA   Hanson D., Murray P.G., Sud A., Temtamy S.A., Aglan M.,
RA   Superti-Furga A., Holder S.E., Urquhart J., Hilton E., Manson F.D.C.,
RA   Scambler P., Black G.C.M., Clayton P.E.;
RT   "The primordial growth disorder 3-M syndrome connects ubiquitination
RT   to the cytoskeletal adaptor OBSL1.";
RL   Am. J. Hum. Genet. 84:801-806(2009).
RN   [8]
RP   INTERACTION WITH CCDC8 AND CUL7.
RX   PubMed=21737058; DOI=10.1016/j.ajhg.2011.05.028;
RA   Hanson D., Murray P.G., O'Sullivan J., Urquhart J., Daly S.,
RA   Bhaskar S.S., Biesecker L.G., Skae M., Smith C., Cole T., Kirk J.,
RA   Chandler K., Kingston H., Donnai D., Clayton P.E., Black G.C.;
RT   "Exome sequencing identifies CCDC8 mutations in 3-M syndrome,
RT   Suggesting that CCDC8 Contributes in a Pathway with CUL7 and OBSL1 to
RT   Control Human Growth.";
RL   Am. J. Hum. Genet. 89:148-153(2011).
RN   [9]
RP   FUNCTION, INTERACTION WITH FBXW8 AND CUL7, AND SUBCELLULAR LOCATION.
RX   PubMed=21572988; DOI=10.1371/journal.pbio.1001060;
RA   Litterman N., Ikeuchi Y., Gallardo G., O'Connell B.C., Sowa M.E.,
RA   Gygi S.P., Harper J.W., Bonni A.;
RT   "An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates
RT   Golgi morphology and dendrite patterning.";
RL   PLoS Biol. 9:E1001060-E1001060(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   FUNCTION, IDENTIFICATION IN THE 3M COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24793695; DOI=10.1016/j.molcel.2014.03.047;
RA   Yan J., Yan F., Li Z., Sinnott B., Cappell K.M., Yu Y., Mo J.,
RA   Duncan J.A., Chen X., Cormier-Daire V., Whitehurst A.W., Xiong Y.;
RT   "The 3M complex maintains microtubule and genome integrity.";
RL   Mol. Cell 54:791-804(2014).
RN   [12]
RP   FUNCTION.
RX   PubMed=24793696; DOI=10.1016/j.molcel.2014.03.046;
RA   Li Z., Pei X.H., Yan J., Yan F., Cappell K.M., Whitehurst A.W.,
RA   Xiong Y.;
RT   "CUL9 mediates the functions of the 3M complex and ubiquitylates
RT   survivin to maintain genome integrity.";
RL   Mol. Cell 54:805-819(2014).
RN   [13]
RP   INVOLVEMENT IN 3M2.
RX   PubMed=23018678; DOI=10.1530/JME-12-0034;
RA   Hanson D., Murray P.G., Coulson T., Sud A., Omokanye A., Stratta E.,
RA   Sakhinia F., Bonshek C., Wilson L.C., Wakeling E., Temtamy S.A.,
RA   Aglan M., Rosser E.M., Mansour S., Carcavilla A., Nampoothiri S.,
RA   Khan W.I., Banerjee I., Chandler K.E., Black G.C., Clayton P.E.;
RT   "Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered
RT   growth factor signalling.";
RL   J. Mol. Endocrinol. 49:267-275(2012).
RN   [14]
RP   STRUCTURE BY NMR OF 615-992.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of Ig-like domains from human obscurin-like
RT   protein 1.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1-105 IN COMPLEX WITH THE
RP   C-TERMINAL IG-LIKE DOMAIN OF TTN, AND INTERACTION WITH TTN.
RX   PubMed=20489725; DOI=10.1038/embor.2010.65;
RA   Sauer F., Vahokoski J., Song Y.H., Wilmanns M.;
RT   "Molecular basis of the head-to-tail assembly of giant muscle proteins
RT   obscurin-like 1 and titin.";
RL   EMBO Rep. 11:534-540(2010).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) OF 1-106 OF WILD-TYPE AND
RP   MUTANT ARG-17 IN COMPLEX WITH THE C-TERMINAL IG-LIKE DOMAIN OF TTN,
RP   INTERACTION WITH TTN, AND MUTAGENESIS OF PHE-17.
RX   PubMed=20133654; DOI=10.1073/pnas.0913736107;
RA   Pernigo S., Fukuzawa A., Bertz M., Holt M., Rief M., Steiner R.A.,
RA   Gautel M.;
RT   "Structural insight into M-band assembly and mechanics from the titin-
RT   obscurin-like-1 complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2908-2913(2010).
RN   [17]
RP   STRUCTURE BY NMR OF 805-892.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR structure of Ig like domain (805-892) of obscurin-like
RT   protein 1 from Homo sapiens, Northeast Structural Genomics Consortium
RT   (NESG) Target HR8578K (CASP Target).";
RL   Submitted (JUN-2012) to the PDB data bank.
RN   [18]
RP   STRUCTURE BY NMR OF 1277-1357.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR Structure of Ig like domain (1277-1357) of Obscurin-like
RT   protein 1 from Homo sapiens, Northeast Structural Genomics Consortium
RT   (NESG) Target HR8578D (CASP Target).";
RL   Submitted (JUN-2012) to the PDB data bank.
CC   -!- FUNCTION: Core component of the 3M complex, a complex required to
CC       regulate microtubule dynamics and genome integrity. It is unclear
CC       how the 3M complex regulates microtubules, it could act by
CC       controlling the level of a microtubule stabilizer
CC       (PubMed:24793695, PubMed:24793696). Acts as a regulator of the
CC       Cul7-RING(FBXW8) ubiquitin-protein ligase, playing a critical role
CC       in the ubiquitin ligase pathway that regulates Golgi morphogenesis
CC       and dendrite patterning in brain. Required to localize CUL7 to the
CC       Golgi apparatus in neurons. {ECO:0000269|PubMed:21572988,
CC       ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.
CC   -!- SUBUNIT: Component of the 3M complex, composed of core components
CC       CUL7, CCDC8 and OBSL1. Interacts with CCDC8. Interacts with CUL7;
CC       the interaction is direct. Interacts with FBXW8. Interacts (via N-
CC       terminal Ig-like domain) with TTN/titin (via C-terminal Ig-like
CC       domain); the interaction is direct. {ECO:0000269|PubMed:20133654,
CC       ECO:0000269|PubMed:20489725, ECO:0000269|PubMed:21572988,
CC       ECO:0000269|PubMed:21737058, ECO:0000269|PubMed:24793695}.
CC   -!- INTERACTION:
CC       Q8WZ42:TTN; NbExp=8; IntAct=EBI-1223896, EBI-681210;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24793695}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:24793695}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:24793695}. Golgi apparatus
CC       {ECO:0000269|PubMed:21572988}. Note=Colocalizes with CUL7 at the
CC       Golgi apparatus in neurons (PubMed:21572988).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O75147-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75147-2; Sequence=VSP_040784, VSP_040785;
CC       Name=3;
CC         IsoId=O75147-1; Sequence=VSP_040786, VSP_040787, VSP_040788;
CC       Name=4;
CC         IsoId=O75147-4; Sequence=VSP_054755, VSP_054756;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with predominant levels
CC       found in the heart. {ECO:0000269|PubMed:17289344}.
CC   -!- DISEASE: 3M syndrome 2 (3M2) [MIM:612921]: An autosomal recessive
CC       disorder characterized by severe pre- and postnatal growth
CC       retardation, facial dysmorphism, large head circumference, and
CC       normal intelligence and endocrine function. Skeletal changes
CC       include long slender tubular bones and tall vertebral bodies.
CC       {ECO:0000269|PubMed:19481195, ECO:0000269|PubMed:23018678}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07201.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF063637; ABO42327.1; -; mRNA.
DR   EMBL; EF063638; ABO42328.1; -; mRNA.
DR   EMBL; AC009955; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007201; AAH07201.1; ALT_INIT; mRNA.
DR   EMBL; AB014557; BAA31632.2; -; mRNA.
DR   CCDS; CCDS46520.1; -. [O75147-3]
DR   CCDS; CCDS54433.1; -. [O75147-2]
DR   CCDS; CCDS63134.1; -. [O75147-4]
DR   RefSeq; NP_001166879.1; NM_001173408.1. [O75147-2]
DR   RefSeq; NP_001166902.1; NM_001173431.1. [O75147-4]
DR   RefSeq; NP_056126.1; NM_015311.2. [O75147-3]
DR   UniGene; Hs.526594; -.
DR   PDB; 2CPC; NMR; -; A=893-992.
DR   PDB; 2E6P; NMR; -; A=714-804.
DR   PDB; 2E6Q; NMR; -; A=615-713.
DR   PDB; 2LU7; NMR; -; A=1277-1357.
DR   PDB; 2LVC; NMR; -; A=805-892.
DR   PDB; 2WP3; X-ray; 1.48 A; O=1-106.
DR   PDB; 2WWK; X-ray; 1.70 A; O=1-106.
DR   PDB; 2WWM; X-ray; 2.30 A; C/O=1-106.
DR   PDB; 3KNB; X-ray; 1.40 A; B=1-105.
DR   PDB; 5FM5; X-ray; 3.10 A; O/P=251-339.
DR   PDBsum; 2CPC; -.
DR   PDBsum; 2E6P; -.
DR   PDBsum; 2E6Q; -.
DR   PDBsum; 2LU7; -.
DR   PDBsum; 2LVC; -.
DR   PDBsum; 2WP3; -.
DR   PDBsum; 2WWK; -.
DR   PDBsum; 2WWM; -.
DR   PDBsum; 3KNB; -.
DR   PDBsum; 5FM5; -.
DR   ProteinModelPortal; O75147; -.
DR   SMR; O75147; -.
DR   BioGrid; 116944; 640.
DR   DIP; DIP-38340N; -.
DR   IntAct; O75147; 15.
DR   MINT; MINT-7979572; -.
DR   STRING; 9606.ENSP00000385636; -.
DR   iPTMnet; O75147; -.
DR   PhosphoSitePlus; O75147; -.
DR   BioMuta; OBSL1; -.
DR   EPD; O75147; -.
DR   PaxDb; O75147; -.
DR   PeptideAtlas; O75147; -.
DR   PRIDE; O75147; -.
DR   Ensembl; ENST00000373873; ENSP00000362980; ENSG00000124006. [O75147-2]
DR   Ensembl; ENST00000404537; ENSP00000385636; ENSG00000124006. [O75147-3]
DR   Ensembl; ENST00000603926; ENSP00000474519; ENSG00000124006. [O75147-4]
DR   GeneID; 23363; -.
DR   KEGG; hsa:23363; -.
DR   UCSC; uc002vmi.4; human. [O75147-3]
DR   CTD; 23363; -.
DR   DisGeNET; 23363; -.
DR   GeneCards; OBSL1; -.
DR   GeneReviews; OBSL1; -.
DR   H-InvDB; HIX0002869; -.
DR   H-InvDB; HIX0161860; -.
DR   HGNC; HGNC:29092; OBSL1.
DR   HPA; HPA036404; -.
DR   HPA; HPA036405; -.
DR   MalaCards; OBSL1; -.
DR   MIM; 610991; gene.
DR   MIM; 612921; phenotype.
DR   neXtProt; NX_O75147; -.
DR   OpenTargets; ENSG00000124006; -.
DR   Orphanet; 2616; 3M syndrome.
DR   PharmGKB; PA142671235; -.
DR   eggNOG; KOG0613; Eukaryota.
DR   eggNOG; ENOG410XQFD; LUCA.
DR   GeneTree; ENSGT00860000133679; -.
DR   HOGENOM; HOG000263472; -.
DR   HOVERGEN; HBG082081; -.
DR   InParanoid; O75147; -.
DR   KO; K19574; -.
DR   OMA; DSVFFNI; -.
DR   OrthoDB; EOG091G0003; -.
DR   PhylomeDB; O75147; -.
DR   ChiTaRS; OBSL1; human.
DR   EvolutionaryTrace; O75147; -.
DR   GeneWiki; OBSL1; -.
DR   GenomeRNAi; 23363; -.
DR   PRO; PR:O75147; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000124006; -.
DR   CleanEx; HS_OBSL1; -.
DR   ExpressionAtlas; O75147; baseline and differential.
DR   Genevisible; O75147; HS.
DR   GO; GO:1990393; C:3M complex; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; TAS:BHF-UCL.
DR   GO; GO:0031430; C:M band; TAS:BHF-UCL.
DR   GO; GO:0005859; C:muscle myosin complex; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; TAS:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0008093; F:cytoskeletal adaptor activity; NAS:BHF-UCL.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IBA:GO_Central.
DR   GO; GO:0008307; F:structural constituent of muscle; IBA:GO_Central.
DR   GO; GO:0097493; F:structural molecule activity conferring elasticity; IBA:GO_Central.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0055003; P:cardiac myofibril assembly; NAS:BHF-UCL.
DR   GO; GO:0007010; P:cytoskeleton organization; NAS:BHF-UCL.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IMP:UniProtKB.
DR   GO; GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:0045214; P:sarcomere organization; IBA:GO_Central.
DR   GO; GO:0006941; P:striated muscle contraction; IBA:GO_Central.
DR   GO; GO:0071688; P:striated muscle myosin thick filament assembly; IBA:GO_Central.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 20.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF07679; I-set; 13.
DR   SMART; SM00409; IG; 19.
DR   SMART; SM00408; IGc2; 14.
DR   SUPFAM; SSF48726; SSF48726; 18.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS50835; IG_LIKE; 14.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disulfide bond; Dwarfism; Golgi apparatus;
KW   Immunoglobulin domain; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN         1   1896       Obscurin-like protein 1.
FT                                /FTId=PRO_0000247959.
FT   DOMAIN       12    100       Ig-like 1.
FT   DOMAIN      128    225       Ig-like 2.
FT   DOMAIN      243    330       Ig-like 3.
FT   DOMAIN      339    425       Ig-like 4.
FT   DOMAIN      517    615       Fibronectin type-III.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      714    800       Ig-like 5.
FT   DOMAIN      804    893       Ig-like 6.
FT   DOMAIN      902    982       Ig-like 7.
FT   DOMAIN      986   1075       Ig-like 8.
FT   DOMAIN     1078   1172       Ig-like 9.
FT   DOMAIN     1174   1261       Ig-like 10.
FT   DOMAIN     1265   1357       Ig-like 11.
FT   DOMAIN     1357   1534       Ig-like 12.
FT   DOMAIN     1628   1720       Ig-like 13.
FT   DOMAIN     1794   1896       Ig-like 14.
FT   REGION       17     19       Interaction with TTN.
FT   REGION       85     94       Interaction with TTN.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   DISULFID     33     84       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    149    209       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    267    319       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    362    412       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    738    788       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    829    879       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    920    970       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID   1011   1061       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID   1103   1153       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID   1195   1245       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID   1381   1522       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID   1650   1700       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     986   1025       PPVRIIYPRDEVTLIAVTLECVVLMCELSREDAPVRWYKD
FT                                -> SYQSQDSSNNNPELCVLLKKPKTRRLWSRFPPWRRTAG
FT                                TE (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040784.
FT   VAR_SEQ    1026   1896       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040785.
FT   VAR_SEQ    1076   1167       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9734811}.
FT                                /FTId=VSP_040786.
FT   VAR_SEQ    1405   1493       VEMAQNGSSRILTLRGCQLGDAGTVTLRAGSTATSARLHVR
FT                                ETELLFLRRLQDVRAEEGQDVCLEVETGRVGAAGAVRWVRG
FT                                GQPLPHD -> RQSCCSYGGCRMCGQRKARTCVSKWRQAEW
FT                                VQRGPCAGCEVGSPCPTTLACPWPRMGTSTASSSMVSYWPT
FT                                RAPTAARATTIAPWPGSA (in isoform 3).
FT                                {ECO:0000303|PubMed:9734811}.
FT                                /FTId=VSP_040787.
FT   VAR_SEQ    1494   1896       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9734811}.
FT                                /FTId=VSP_040788.
FT   VAR_SEQ    1537   1543       PRQLRVL -> RECPVLS (in isoform 4).
FT                                {ECO:0000303|PubMed:17289344}.
FT                                /FTId=VSP_054755.
FT   VAR_SEQ    1544   1896       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:17289344}.
FT                                /FTId=VSP_054756.
FT   MUTAGEN      17     17       F->R: Diminishes binding affinity for
FT                                TTN. {ECO:0000269|PubMed:20133654}.
FT   CONFLICT    165    165       G -> R (in Ref. 4; BAA31632).
FT                                {ECO:0000305}.
FT   CONFLICT    512    512       C -> CG (in Ref. 1; ABO42327).
FT                                {ECO:0000305}.
FT   CONFLICT    723    723       R -> K (in Ref. 3; AAH07201 and 4;
FT                                BAA31632). {ECO:0000305}.
FT   CONFLICT   1365   1365       E -> D (in Ref. 4; BAA31632).
FT                                {ECO:0000305}.
FT   STRAND       10     16       {ECO:0000244|PDB:3KNB}.
FT   STRAND       21     24       {ECO:0000244|PDB:3KNB}.
FT   STRAND       29     39       {ECO:0000244|PDB:3KNB}.
FT   STRAND       42     47       {ECO:0000244|PDB:3KNB}.
FT   STRAND       56     59       {ECO:0000244|PDB:3KNB}.
FT   STRAND       66     73       {ECO:0000244|PDB:3KNB}.
FT   HELIX        76     78       {ECO:0000244|PDB:3KNB}.
FT   STRAND       80     88       {ECO:0000244|PDB:3KNB}.
FT   STRAND       91    102       {ECO:0000244|PDB:3KNB}.
FT   STRAND      254    258       {ECO:0000244|PDB:5FM5}.
FT   STRAND      261    267       {ECO:0000244|PDB:5FM5}.
FT   STRAND      269    273       {ECO:0000244|PDB:5FM5}.
FT   STRAND      276    281       {ECO:0000244|PDB:5FM5}.
FT   STRAND      290    296       {ECO:0000244|PDB:5FM5}.
FT   STRAND      300    306       {ECO:0000244|PDB:5FM5}.
FT   HELIX       311    313       {ECO:0000244|PDB:5FM5}.
FT   STRAND      315    322       {ECO:0000244|PDB:5FM5}.
FT   STRAND      327    337       {ECO:0000244|PDB:5FM5}.
FT   STRAND      618    620       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      625    628       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      632    641       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      646    651       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      669    672       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      678    685       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      692    699       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      702    711       {ECO:0000244|PDB:2E6Q}.
FT   STRAND      724    732       {ECO:0000244|PDB:2E6P}.
FT   STRAND      748    751       {ECO:0000244|PDB:2E6P}.
FT   STRAND      762    767       {ECO:0000244|PDB:2E6P}.
FT   STRAND      770    777       {ECO:0000244|PDB:2E6P}.
FT   TURN        780    782       {ECO:0000244|PDB:2E6P}.
FT   STRAND      784    789       {ECO:0000244|PDB:2E6P}.
FT   STRAND      797    802       {ECO:0000244|PDB:2E6P}.
FT   STRAND      815    818       {ECO:0000244|PDB:2LVC}.
FT   STRAND      825    830       {ECO:0000244|PDB:2LVC}.
FT   STRAND      839    842       {ECO:0000244|PDB:2LVC}.
FT   STRAND      854    858       {ECO:0000244|PDB:2LVC}.
FT   STRAND      861    868       {ECO:0000244|PDB:2LVC}.
FT   HELIX       871    873       {ECO:0000244|PDB:2LVC}.
FT   STRAND      875    880       {ECO:0000244|PDB:2LVC}.
FT   STRAND      885    891       {ECO:0000244|PDB:2LVC}.
FT   STRAND      898    902       {ECO:0000244|PDB:2CPC}.
FT   STRAND      906    911       {ECO:0000244|PDB:2CPC}.
FT   STRAND      916    923       {ECO:0000244|PDB:2CPC}.
FT   STRAND      930    933       {ECO:0000244|PDB:2CPC}.
FT   STRAND      944    948       {ECO:0000244|PDB:2CPC}.
FT   STRAND      950    959       {ECO:0000244|PDB:2CPC}.
FT   TURN        962    964       {ECO:0000244|PDB:2CPC}.
FT   STRAND      966    974       {ECO:0000244|PDB:2CPC}.
FT   STRAND      976    984       {ECO:0000244|PDB:2CPC}.
FT   STRAND     1279   1281       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1287   1290       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1301   1304       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1313   1319       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1324   1330       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1337   1342       {ECO:0000244|PDB:2LU7}.
FT   TURN       1344   1346       {ECO:0000244|PDB:2LU7}.
FT   STRAND     1348   1354       {ECO:0000244|PDB:2LU7}.
SQ   SEQUENCE   1896 AA;  206947 MW;  6D592AC3E30E9ACA CRC64;
     MKASSGDQGS PPCFLRFPRP VRVVSGAEAE LKCVVLGEPP PVVVWEKGGQ QLAASERLSF
     PADGAEHGLL LTAALPTDAG VYVCRARNAA GEAYAAAAVT VLEPPASDPE LQPAERPLPS
     PGSGEGAPVF LTGPRSQWVL RGAEVVLTCR AGGLPEPTLY WEKDGMALDE VWDSSHFALQ
     PGRAEDGPGA SLALRILAAR LPDSGVYVCH ARNAHGHAQA GALLQVHQPP ESPPADPDEA
     PAPVVEPLKC APKTFWVNEG KHAKFRCYVM GKPEPEIEWH WEGRPLLPDR RRLMYRDRDG
     GFVLKVLYCQ AKDRGLYVCA ARNSAGQTLS AVQLHVKEPR LRFTRPLQDV EGREHGIAVL
     ECKVPNSRIP TAWFREDQRL LPCRKYEQIE EGTVRRLIIH RLKADDDGIY LCEMRGRVRT
     VANVTVKGPI LKRLPRKLDV LEGENAVLLV ETLEAGVEGR WSRDGEELPV ICQSSSGHMH
     ALVLPGVTRE DAGEVTFSLG NSRTTTLLRV KCVKHSPPGP PILAEMFKGH KNTVLLTWKP
     PEPAPETPFI YRLERQEVGS EDWIQCFSIE KAGAVEVPGD CVPSEGDYRF RICTVSGHGR
     SPHVVFHGSA HLVPTARLVA GLEDVQVYDG EDAVFSLDLS TIIQGTWFLN GEELKSNEPE
     GQVEPGALRY RIEQKGLQHR LILHAVKHQD SGALVGFSCP GVQDSAALTI QESPVHILSP
     QDRVSLTFTT SERVVLTCEL SRVDFPATWY KDGQKVEESE LLVVKMDGRK HRLILPEAKV
     QDSGEFECRT EGVSAFFGVT VQDPPVHIVD PREHVFVHAI TSECVMLACE VDREDAPVRW
     YKDGQEVEES DFVVLENEGP HRRLVLPATQ PSDGGEFQCV AGDECAYFTV TITDVSSWIV
     YPSGKVYVAA VRLERVVLTC ELCRPWAEVR WTKDGEEVVE SPALLLQKED TVRRLVLPAV
     QLEDSGEYLC EIDDESASFT VTVTEPPVRI IYPRDEVTLI AVTLECVVLM CELSREDAPV
     RWYKDGLEVE ESEALVLERD GPRCRLVLPA AQPEDGGEFV CDAGDDSAFF TVTVTAPPER
     IVHPAARSLD LHFGAPGRVE LRCEVAPAGS QVRWYKDGLE VEASDALQLG AEGPTRTLTL
     PHAQPEDAGE YVCETRHEAI TFNVILAEPP VQFLALETTP SPLCVAPGEP VVLSCELSRA
     GAPVVWSHNG RPVQEGEGLE LHAEGPRRVL CIQAAGPAHA GLYTCQSGAA PGAPSLSFTV
     QVAEPPVRVV APEAAQTRVR STPGGDLELV VHLSGPGGPV RWYKDGERLA SQGRVQLEQA
     GARQVLRVQG ARSGDAGEYL CDAPQDSRIF LVSVEEPLLV KLVSELTPLT VHEGDDATFR
     CEVSPPDADV TWLRNGAVVT PGPQVEMAQN GSSRILTLRG CQLGDAGTVT LRAGSTATSA
     RLHVRETELL FLRRLQDVRA EEGQDVCLEV ETGRVGAAGA VRWVRGGQPL PHDSRLSMAQ
     DGHIHRLFIH GVILADQGTY GCESHHDRTL ARLSVRPRQL RVLRPLEDVT ISEGGSATFQ
     LELSQEGVTG EWARGGVQLY PGPKCHIHSD GHRHRLVLNG LGLADSGCVS FTADSLRCAA
     RLIVREVPVT IVRGPHDLEV TEGDTATFEC ELSQALADVT WEKDGNALTP SPRLRLQALG
     TRRLLQLRRC GPSDAGTYSC AVGTARAGPV RLTVRERTVA VLSELRSVSA REGDGATFEC
     TVSEVETTGR WELGGRPLRP GARVRIRQEG KKHILVLSEL RAEDAGEVRF QAGPAQSLAL
     LEVEALPLQM CRHPPREKTV LVGRRAVLEV TVSRSGGHVC WLREGAELCP GDKYEMRSHG
     PTHSLVIHDV RPEDQGTYCC QAGQDSTHTR LLVEGN
//
